public workshop: safety assessment for investigational new drug reporting
Published Streamed 6 years ago • 1.9K plays • Length 7:07:30Download video MP4
Download video MP3
Similar videos
-
55:28
overview of cder - sentinel initiative public workshop
-
4:42:49
duke margolis-fda workshop: advancing premarket safety analytics
-
35:38
safety reporting requirements and safety assessment for ind and ba/be studies
-
6:56:53
public workshop: a framework for regulatory use of real-world evidence
-
41:11
perspectives from fda's leadership - sentinel initiative public workshop
-
3:46
what is a risk assessment? | 4 key elements & how to perform a risk assessment | safetyculture
-
4:57
medicare drug prices; vp debate
-
1:01:42
risk assessments
-
15:54
advancing premarket safety analytics intro
-
3:43:48
fda public workshop on opioid prescriber education day 1
-
1:17:44
sentinel initiative public workshop part 4
-
2:05:11
understanding how the public perceives and values pharmaceutical quality - rec
-
1:21:49
advancing premarket safety analytics stakeholder exploring premarket adverse event grouping
-
1:04:27
fda innovation and safety act
-
7:52:15
2018 sentinel initiative annual public workshop
-
1:16:34
advancing premarket safety analytics overview of the standard safety tables/figures integrated guide
-
8:02:14
public workshop: oncology clinical trials in the presence of non-proportional hazards
-
7:18:32
sentinel initiative public workshop
-
51:35
advancing premarket safety analytics fda medical queries
-
2:11:46
understanding how the public perceives and values pharmaceutical quality
-
6:09:16
characterizing fda’s approach to benefit-risk assessment throughout the medical product life cycle
-
7:43:38
strategies for promoting the safe use and appropriate prescribing of prescription opioids